Pediatric Waivers Contingent On Study Attempts In Sub-Populations - FDA
Executive Summary
Sponsors may have to attempt pediatric studies in small patient populations before FDA grants a pediatric waiver, FDA suggests in a list of "Frequently Asked Questions on Pediatric Exclusivity (505A), The Pediatric 'Rule,' and Their Interaction" posted on its website July 27.